GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Indivior PLC
Indivior is a pharmaceutical company specializing in the treatment of opioid addiction. Its stock price is heavily dependent on sales of its flagship drug, Sublocade, and the legal risks associated with its previous blockbuster, Suboxone.
Share prices of companies in the market segment - Narco farm
Indivior is a pharmaceutical company specializing in the treatment of opioid addiction. We classify it as part of the addiction pharmaceuticals sector, and the chart below illustrates the overall dynamics of this complex market, subject to regulation and litigation.
Broad Market Index - GURU.Markets
Indivior is a pharmaceutical company specializing in the development of drugs to treat opioid addiction and other mental health disorders. Its focus on this social issue makes it a prominent player in the GURU.Markets index. The chart below represents the entire market. Find out how Indivior compares to it.
Change in the price of a company, segment, and market as a whole per day
INDV - Daily change in the company's share price Indivior PLC
The price fluctuations of Indivior, a pharmaceutical company specializing in addiction treatment, reflect its high sensitivity to litigation and generic competition. Change_co demonstrates volatility associated with regulatory risks. This metric is important for analyzing companies in complex pharmaceutical segments on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Narco farm
Indivior PLC is a pharmaceutical company specializing in addiction treatment. This chart highlights the sector's high volatility. Comparing this to INDV, whose revenue is heavily dependent on a single drug, helps assess its high concentration risks and generic competition.
Daily change in the price of a broad market stock, index - GURU.Markets
Indivior is a pharmaceutical company specializing in medications for the treatment of addictions and mental health disorders. This segment of the pharmaceutical industry is highly volatile and under close regulatory scrutiny. The chart below reflects the average fluctuations in this niche, helping to assess Indivior's risks and potential.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Indivior PLC
Indivior is a pharmaceutical company specializing in the treatment of opioid addiction. Its year-over-year performance reflects both the demand for its medications and the complex legal and regulatory risks associated with this sensitive area.
Annual dynamics of market capitalization of the market segment - Narco farm
Indivior PLC is a pharmaceutical company specializing in the treatment of addiction and mental health disorders. Its success is heavily dependent on its key drug for the treatment of opioid addiction. The chart shows how generic competition and new product development are impacting its performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Indivior, specializing in opioid addiction treatment, operates in a unique healthcare niche. Its stock price is driven not by the economy, but by the sales volume of its medications, generic competition, and lawsuits. The chart is a complex story, intertwining medical, legal, and social factors.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Indivior PLC
The value of Indivior, a pharmaceutical company specializing in addiction treatment, depends on its product cycle. The monthly fluctuations on the chart reflect sales data for its key drug, Sublocade, its market share, and news related to patent protection and litigation in the opioid sector.
Monthly dynamics of market capitalization of the market segment - Narco farm
Indivior PLC is a pharmaceutical company specializing in the development of drugs for the treatment of opioid addiction and other central nervous system disorders. Its sector dynamics, shown in the chart, reflect both risks and social significance. Against this backdrop, it's possible to assess how its leadership in its niche and legal risks impact the company's position.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Indivior is a pharmaceutical company specializing in the treatment of opioid addiction. Its business is heavily dependent on a single key drug and legal risks. The chart below shows how the company's stock has lived its own life, with its performance driven by legal decisions and competition rather than by overall market trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Indivior PLC
Shares of Indivior, a company specializing in opioid addiction treatment, are highly dependent on healthcare and legal news. Weekly performance reflects regulatory decisions, litigation outcomes, and competition in the drug market. The chart below illustrates the high volatility associated with these specific risks.
Weekly dynamics of market capitalization of the market segment - Narco farm
How does Indivior's performance compare to the pharmaceutical sector? The chart below compares the addiction treatment company's weekly stock price movements with the industry average. This helps us understand whether its sharp movements are a unique response to lawsuits and regulatory decisions or reflect broader trends across pharmaceutical companies.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Indivior PLC specializes in opioid addiction treatment. Its business is heavily dependent on one key product and legal risks. This chart compares its weekly performance to the market, showing how its shares can move unpredictably and counter-trend due to court rulings or regulatory announcements.
Market capitalization of the company, segment and market as a whole
INDV - Market capitalization of the company Indivior PLC
Indivior PLC's market capitalization reflects its dominant, yet controversial, position in the opioid addiction treatment market. The company's market capitalization is closely tied to sales of its key drug, Sublocade, and ongoing legal risks. Its dynamics reveal how investors weigh commercial success against reputational threats.
INDV - Share of the company's market capitalization Indivior PLC within the market segment - Narco farm
Indivior PLC specializes in developing medications for the treatment of addictions and serious mental disorders. Its share of the market capitalization of its pharmaceutical segment reflects its leadership in the treatment of opioid addiction. The chart shows the market value of its key drugs and the risks associated with patent protection and litigation.
Market capitalization of the market segment - Narco farm
This chart is a barometer of the pharmaceutical segment dedicated to addiction treatment. Indivior PLC is a global leader in this complex and socially significant niche. The dynamics on the chart reflect both treatment advances and the legal and regulatory risks inherent in this market.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart depicts the market value of addiction treatment. The market capitalization of Indivior, which specializes in opioid addiction treatment, reflects the severity of this social problem. The line shows how a pharmaceutical company operating in a complex and regulated niche shapes its share of the global healthcare economy.
Book value capitalization of the company, segment and market as a whole
INDV - Book value capitalization of the company Indivior PLC
Indivior PLC's book value represents its intellectual and production capital. The chart below reflects the valuation of its patents for drugs used to treat addiction and mental disorders, as well as its manufacturing capacity. This dynamic illustrates how the company is investing in protecting and expanding its unique product portfolio.
INDV - Share of the company's book capitalization Indivior PLC within the market segment - Narco farm
Indivior, a company specializing in addiction treatment, has manufacturing facilities and R&D centers for developing complex pharmaceuticals. The chart shows the company's share of the physical infrastructure in this highly specialized yet socially significant area of pharmacology.
Market segment balance sheet capitalization - Narco farm
Indivior PLC is a pharmaceutical company specializing in addiction treatment. It not only develops but also manufactures its drugs, making it more capital-intensive than pure R&D companies. The chart will show whether this mixed model is the norm for the entire pharmaceutical industry.
Book value of all companies included in the broad market index - GURU.Markets
Indivior's balance sheet consists of intellectual property and manufacturing capabilities focused on treating opioid addiction. The company's assets represent capital dedicated to solving one of the most pressing social problems. The chart shows the company's financial and scientific weight in this complex area of pharmacology.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Indivior PLC
Indivior specializes in treating opioid addiction. Its balance sheet reflects its R&D and manufacturing capabilities, but its primary value lies in the patents on its medications, particularly its long-acting injectable formulations. The chart shows how the market views its dominance in this complex therapeutic niche and the risks associated with patent disputes and generics.
Market to book capitalization ratio in a market segment - Narco farm
Indivior specializes in opioid addiction treatments. It's a highly niche and controversial pharmaceutical business. The company's value is determined by its patents and market share. The chart shows how the market views its prospects, taking into account both the drug's potential and the high legal risks.
Market to book capitalization ratio for the market as a whole
Indivior PLC specializes in developing medications for the treatment of addictions and mental disorders. This chart shows how the market values the company in this complex and socially significant niche. Its value is highly dependent on the success of its key drugs, patent protection, and litigation outcomes, creating high volatility in its valuation relative to its assets.
Debts of the company, segment and market as a whole
INDV - Company debts Indivior PLC
Indivior specializes in developing medications for the treatment of addictions and serious mental illnesses. This is a risky field, requiring significant investment in R&D and complex regulatory procedures. This chart shows how the company utilizes financial resources, including debt, to advance its life-saving drugs.
Market segment debts - Narco farm
Indivior is a pharmaceutical company specializing in the treatment of addictions and serious mental disorders. This is a highly specialized and socially significant segment of the pharmaceutical market. This chart shows general financial metrics for the industry, which can be used to analyze how Indivior funds the development and commercialization of its life-saving drugs.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Indivior PLC
Indivior specializes in developing medications for the treatment of addictions, particularly opioids. This market is socially significant, but also legally complex. This chart shows the company's financial structure and its debt exposure, which is important for assessing the risks associated with litigation and generic competition.
Market segment debt to market segment book capitalization - Narco farm
Indivior specializes in treating addictions and serious mental health disorders, occupying a complex but important niche in the pharmaceutical industry. This chart compares the company's debt to the total market capitalization of the entire addiction treatment sector. It helps assess how the company finances the development and marketing of its life-saving drugs.
Debt to book value of all companies in the market
Indivior operates in the complex addiction treatment niche. This chart compares the company's debt to the overall book value of the entire economy. It helps assess how the company finances its important social mission and the associated legal and regulatory risks within the context of overall market conditions.
P/E of the company, segment and market as a whole
P/E - Indivior PLC
This metric for Indivior PLC, a pharmaceutical company specializing in addiction treatment, reflects investors' assessment of its niche market. It is sensitive to news about patent protection for its key drugs and the emergence of competitors. The chart helps understand how the market weighs current profitability against future risks associated with loss of exclusivity.
P/E of the market segment - Narco farm
This chart shows the average valuation for the specialty pharmaceutical sector in which Indivior operates. This metric reflects how investors generally value companies operating in niches with high barriers to entry. It helps us understand whether Indivior's valuation reflects a premium for its leadership in addiction treatment.
P/E of the market as a whole
Indivior PLC specializes in developing medications for the treatment of addictions and serious mental illnesses. The company operates in a complex yet socially important field of medicine. This chart, reflecting investor attitudes toward risk, helps assess how the market views pharmaceutical companies with a narrow yet important focus.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Indivior PLC
Indivior specializes in developing medications for the treatment of addictions and serious mental disorders. This chart shows market expectations for future sales of its drugs, which depend on patent protection and generic competition. It represents the market's assessment of the company's ability to defend its niche and introduce new products.
%20P%2FE%20Indivior%20PLC&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Indivior-PLC&v=1772603035169 "Chart of the company's future (projected) P/E Indivior PLC")
Future (projected) P/E of the market segment - Narco farm
Indivior is a global pharmaceutical company specializing in the development and commercialization of medications for the treatment of addiction and serious mental illnesses. The company's flagship product is designed to treat opioid addiction. This chart shows overall market sentiment regarding the pharmaceutical sector, helping to assess Indivior's potential in its complex niche.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Narco-farm&v=1772603035184 "Future (projected) P/E graph of the market segment - Narco farm")
Future (projected) P/E of the market as a whole
Indivior PLC specializes in developing medications to treat opioid addiction and other central nervous system disorders. Demand for its products is driven by the scale of the addiction crisis and healthcare policy, not economic cycles. This makes its business socially important, but also risky.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772603035190 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Indivior PLC
Indivior is a pharmaceutical company specializing in the development of drugs for the treatment of addictions and serious mental disorders. Its financial performance is largely dependent on sales of its key drugs and generic competition. This chart shows how the patent cycle and new product launches impact the company's profitability and future.
Profit of companies in the market segment - Narco farm
Indivior PLC is a pharmaceutical company specializing in the development of drugs for the treatment of addictions, primarily opioids. This chart reflects the overall profitability of its narrow but socially significant segment. The company's financial results depend on the effectiveness of its drugs, generic competition, and government drug control policies.
Overall market profit
Indivior PLC is a pharmaceutical company specializing in the treatment of addictions and serious mental disorders. Demand for its medications is driven by public health and medical needs, not economic cycles. Amid the general market fluctuations shown in this chart, Indivior addresses deep-seated social issues, making its business less cyclical.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Indivior PLC
Indivior is a pharmaceutical company specializing in the development of addiction treatments, primarily opioid addiction. The future profit projections reflected here depend on sales of its key drugs and generic competition. This chart shows how analysts assess the company's ability to protect its intellectual property and combat the addiction crisis.
%20profit%20of%20the%20company%20Indivior%20PLC&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Indivior-PLC&v=1772603035231 "Graph of future (projected) profit of the company Indivior PLC")
Future (predicted) profit of companies in the market segment - Narco farm
Indivior PLC is a pharmaceutical company specializing in the development of drugs for the treatment of addictions, primarily opioids. This chart shows profitability forecasts for the drug treatment segment of the pharmaceutical company. It reflects expectations related to government policies to combat addiction and the demand for effective treatment methods.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Narco-farm&v=1772603035244 "Graph of future (predicted) profits of companies in a market segment - Narco farm")
Future (predicted) profit of the market as a whole
Indivior PLC specializes in developing medications for the treatment of addictions and serious mental illnesses. Demand for these therapies is driven by healthcare needs, not economic cycles. However, the overall market profit forecast reflected here impacts government budgets and the ability of healthcare systems to fund treatment programs, which is important to Indivior.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772603035266 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Indivior PLC
Indivior PLC specializes in medications for the treatment of opioid addiction. Demand for its products is driven by a serious social problem. The price-to-sales ratio reflects how investors assess the company's dominant position in this market and the potential of its new developments, despite patent and legal risks.
P/S market segment - Narco farm
Indivior PLC specializes in developing medications for the treatment of addiction and serious mental illnesses. Their revenue was heavily dependent on a single blockbuster, and now the company is diversifying its portfolio. This chart reflects how the market views their ability to launch new products and offset the loss of exclusivity on existing ones.
P/S of the market as a whole
Indivior PLC specializes in developing medications to treat opioid addiction. The company's revenue is highly dependent on the success of its key drugs and generic competition. This overall revenue estimate chart provides an insight into how the market perceives the pharmaceutical company's earnings, operating in a socially complex and highly regulated niche.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Indivior PLC
Indivior specializes in developing medications for the treatment of addictions, primarily opioids. The company's future depends on the success of its drugs and the fight against generics. This metric reflects market expectations for future sales of its key products, taking into account the patent situation and the dynamics of the addiction treatment market.
%20P%2FS%20Indivior%20PLC&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Indivior-PLC&v=1772603035303 "The graph of the company's future (projected) P/S Indivior PLC")
Future (projected) P/S of the market segment - Narco farm
Indivior PLC is a pharmaceutical company specializing in the development of medications for the treatment of addictions, particularly opioid addiction, and serious mental illnesses. This chart shows how the market views the future sales of its drugs compared to other pharmaceutical companies, reflecting its views on the development of the addiction treatment market and its competitive position.
%20P%2FS%20market%20segment%20graph%20-%20Narco%20farm&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Narco-farm&v=1772603035314 "Future (projected) P/S market segment graph - Narco farm")
Future (projected) P/S of the market as a whole
Indivior specializes in developing medications to treat opioid addiction and other mental health disorders. The company operates at the intersection of pharmaceuticals and addressing a pressing social issue. This chart reflects overall sales expectations, and Indivior demonstrates how the business can grow by addressing the most complex healthcare challenges.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772603035330 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Indivior PLC
Indivior PLC is a pharmaceutical company specializing in the development of medications for the treatment of addiction and serious mental illnesses. This chart shows its revenue, which is primarily generated by sales of opioid addiction treatments. Sales dynamics depend on generic competition and the success of new products in the portfolio.
Sales of companies in the market segment - Narco farm
Indivior is a pharmaceutical company specializing in the treatment of addictions and serious mental illnesses. This chart segments revenue by its key drugs, such as Sublocade. This allows investors to track the product lifecycle and evaluate the company's success in bringing new drugs to market.
Overall market sales
Indivior PLC specializes in developing medications for the treatment of addictions, particularly opioids. Demand for its products is driven by the scale of the public health crisis, not economic cycles. This chart does not reflect Indivior's key business drivers, which lie in the medical, social, and regulatory sectors.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Indivior PLC
Indivior specializes in developing medications for the treatment of opioid addiction and other central nervous system disorders. The company's revenue outlook is closely tied to the success of its key drugs and the fight against generics. This chart shows how analysts assess its ability to maintain market share and commercialize new therapies.
%20sales%20of%20the%20company%20Indivior%20PLC&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Indivior-PLC&v=1772603035379 "Schedule of future (projected) sales of the company Indivior PLC")
Future (projected) sales of companies in the market segment - Narco farm
Indivior PLC specializes in developing medications for the treatment of addictions and serious mental illnesses. This chart shows projected revenues for the entire drug treatment pharmaceutical segment. It allows one to assess whether analysts see growth potential in this socially significant market, which is critical to the commercial prospects of Indivior's products.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Narco-farm&v=1772603035395 "Schedule of future (projected) sales of companies in the market segment - Narco farm")
Future (projected) sales of the market as a whole
Indivior specializes in developing medications for the treatment of opioid addiction and other central nervous system disorders. Demand for its products is determined by the scale of the addiction crisis and healthcare policy. This broad economic outlook indirectly impacts government budgets, which underpin the funding of treatment programs and drug reimbursement.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772603035401 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Indivior PLC
Indivior specializes in developing medications for the treatment of addictions and serious mental disorders. This chart reflects the company's financial performance, whose success is closely tied to several key drugs. Its profitability depends on patent protection, generic competition, and the successful launch of new treatments.
Market segment marginality - Narco farm
Indivior specializes in developing medications for the treatment of addiction, primarily opioids. This chart reflects the commercial success of its drugs in this complex therapeutic area. High profitability reflects its market leadership, strong intellectual property, and high demand for its treatments.
Market marginality as a whole
Indivior PLC specializes in developing medications for the treatment of addictions, primarily opioids. This market is both socially significant and legally complex. This overall profitability chart reveals little about Indivior's prospects, which depend on court decisions, regulatory actions, and the success of new drugs.
Employees in the company, segment and market as a whole
Number of employees in the company Indivior PLC
Indivior PLC is a pharmaceutical company specializing in the treatment of addictions, particularly opioid addiction. Its team includes research staff and a large sales and marketing department to promote its drugs. The dynamics of this graph may reflect the life cycle of key products and efforts to bring new therapies to market.
Share of the company's employees Indivior PLC within the market segment - Narco farm
Indivior PLC is a pharmaceutical company specializing in the treatment of addictions and serious mental illnesses. This chart demonstrates its dominance in its narrow but socially significant niche. It reflects the significant share of scientists, physicians, and commercial specialists working in the field of addiction treatment that Indivior houses.
Number of employees in the market segment - Narco farm
Indivior PLC is a pharmaceutical company specializing in the development of medications for the treatment of addictions, primarily opioids. This chart reflects the market share in the addiction treatment niche. Growth in this area, unfortunately, reflects the severity of the drug addiction problem, but also indicates increased treatment efforts, expanding the market for Indivior's medications.
Number of employees in the market as a whole
Indivior PLC specializes in developing medications to treat opioid addiction. Demand for its products, and consequently employment, is driven by the scale of the public health crisis. It is an example of a company whose growth is tied to addressing a pressing social issue rather than general economic trends.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Indivior PLC (INDV)
Indivior is a pharmaceutical company specializing in the treatment of addictions and mental health disorders. Their value is determined by both sales of existing drugs and the potential of new developments. This chart shows that in the pharmaceutical industry, even commercial companies with manufacturing and distribution maintain high costs per employee due to the value of their intellectual property.
%20of%20the%20company%20Indivior%20PLC%20(INDV)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Indivior-PLC-INDV&v=1772603035668 "Chart of market capitalization per employee (in thousands of dollars) of the company Indivior PLC (INDV)")
Market capitalization per employee (in thousands of dollars) in the market segment - Narco farm
Indivior is a pharmaceutical company specializing in the treatment of addiction (primarily opioid addiction) and mental health disorders. Its success is based on long-acting medications. This chart shows the industry average. It helps assess the market value generated by Indivior's R&D and commercial teams in this complex niche.
%20by%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Narco-farm&v=1772603035679 "Market capitalization per employee (in thousands of dollars) by market segment - Narco farm")
Market capitalization per employee (in thousands of dollars) for the overall market
Indivior specializes in developing drugs to treat addictions and serious mental disorders. This is a highly specialized area of pharmaceuticals that requires deep scientific expertise. This chart reflects how highly the market values the intellectual capital of a team working to solve complex medical and social problems.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772603035722 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Indivior PLC (INDV)
Indivior is a pharmaceutical company specializing in the treatment of addiction (especially opioid addiction) and mental health disorders. Its success was built on the drug Suboxone. This chart shows how effectively the company manages its narrow but high-margin drug portfolio, especially in the face of patent cliffs and litigation.
%20Chart%20Indivior%20PLC%20(INDV)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Indivior-PLC-INDV&v=1772603035769 "Company Profit Per Employee (in thousands of dollars) Chart Indivior PLC (INDV)")
Profit per employee (in thousands of dollars) in the market segment - Narco farm
Indivior is a "specialty" pharma focused on treating *addictions* (opioid addiction, alcoholism). This chart shows the benchmark for "Specialty Pharma." In this sector, the benchmark is high. Revenue per employee is generated by "patents" on niche, "complex" drugs, which ensures high margins.
%20in%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Narco-farm&v=1772603035804 "Chart of profit per employee (in thousands of dollars) in the market segment - Narco farm")
Profit per employee (in thousands of dollars) for the market as a whole
Indivior is a pharmaceutical company specializing exclusively in the treatment of drug addiction (primarily opioid addiction). Their key product is Suboxone. It's a highly specialized pharmaceutical. This chart, which shows the average market profitability per employee, helps us understand how profitable this niche sector is per specialist.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772603035815 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Indivior PLC (INDV)
Indivior PLC is a pharmaceutical company specializing in addiction treatment. This chart shows its commercial performance in a highly specialized market. Revenue per employee depends on the success of its key drugs and its ability to protect patents. The dynamics reflect the product life cycle and competitive environment.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Indivior-PLC-INDV&v=1772603035853 "Sales chart per company employee Indivior PLC (INDV)")
Sales per employee in the market segment - Narco farm
Indivior is a pharmaceutical company specializing in addiction treatment, particularly opioid addiction. It's a highly specialized market. This chart shows the average revenue per employee in this segment. It helps evaluate how productive Indivior's team is in producing and marketing its drugs compared to other pharmaceutical companies.
Sales per employee for the market as a whole
Indivior is a pharmaceutical company specializing in addiction treatment (for example, opioid addiction). This is a highly specialized market. This metric reflects how successfully the company is commercializing its drugs (for example, Sublocade). The rising graph shows that their sales team is effectively working with doctors, and demand for their therapy is growing.
Short shares by company, segment and market as a whole
Shares shorted by company Indivior PLC (INDV)
Indivior PLC is a pharmaceutical company whose fate depends almost entirely on a single product: Suboxone (and its derivatives), a drug for treating opioid addiction. This chart shows the odds that this monopoly will collapse. "Bears" are betting that generic competition and lawsuits will finally destroy the company's dominance.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Indivior-PLC-INDV&v=1772603035984 "Short Shares Chart for the Company Indivior PLC (INDV)")
Shares shorted by market segment - Narco farm
Indivior specializes in treating opioid addiction and other central nervous system disorders (e.g., Suboxone). This business is highly dependent on regulation and patent protection. This chart shows the pessimism in the sector. The increase in short positions may indicate investors' fears of new generic versions, lawsuits, or increased government regulation of the market.
Shares shorted by the overall market
Indivior (INDV) is a pharmaceutical company specializing in the treatment of addiction (opioid) and mental health disorders. Their business relies on government programs and physician prescriptions. This chart measures overall market fear. Although the sector is "defensive," rising fear may reflect investor concerns about litigation risks (related to the opioid crisis) or pricing pressure from generics.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Indivior PLC (INDV)
Indivior specializes in opioid addiction treatments. The business carries regulatory and litigation risks. This chart shows an INDV above 70, which may reflect strong sales of the key drug. A level below 30 is often associated with concerns about generic competition or negative court rulings.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Indivior-PLC-INDV&v=1772603036137 "RSI 14 indicator chart for the company's stock Indivior PLC (INDV)")
RSI 14 Market Segment - Narco farm
Indivior PLC is a pharmaceutical company specializing in the treatment of opioid addiction (Suboxone/Sublocade) and other CNS disorders. This metric measures the overall momentum in the CNS and addiction-related pharmaceutical sector. It helps differentiate INDIV from the overall industry trend.
RSI 14 for the overall market
Indivior (INDV) produces medications for the treatment of opioid addiction. This schedule is less important to the company than decisions by regulators and courts. Demand for its products is, unfortunately, stable. However, market panic could exacerbate social problems, which, while increasing demand, also increases government pressure on prices.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast INDV (Indivior PLC)
Indivior PLC is a pharmaceutical company specializing in the treatment of addiction (opioid) and mental health disorders. This chart shows the average target price. Analysts' forecasts depend on the success of its long-acting (injectable) medications, generic competition, and the regulatory environment surrounding addiction treatment.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-INDV-Indivior-PLC&v=1772603036223 "A chart showing analyst consensus forecasts for the expected stock price. INDV (Indivior PLC)")
The difference between the consensus estimate and the actual stock price INDV (Indivior PLC)
Indivior is a pharmaceutical company focused almost entirely on a single, but large, therapeutic area: opioid addiction treatment. Their key drugs are Suboxone and Sublocade (a long-acting injection). This chart shows how analysts assess their dominance in this specialized market. It reflects the gap between their target price and the current price.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-INDV-Indivior-PLC&v=1772603036252 "A chart showing the difference between the consensus forecast and the actual stock price. INDV (Indivior PLC)")
Analyst consensus forecast for stock prices by market segment - Narco farm
Indivior is a pharmaceutical company focused on treating *addictions*, primarily opioid addiction (its flagship drug is Sublocade/Suboxone). This chart shows analysts' overall expectations for the entire sector. It reflects whether experts believe the addiction treatment market will grow or whether they see risks (generics, lawsuits).
Analysts' consensus forecast for the overall market share price
Indivior (INDV) is a pharmaceutical company specializing in the treatment of addiction (opioid) and mental health disorders. Their key product helps people overcome drug dependence. This chart shows the overall market sentiment. It reflects analysts' confidence in the sustainability of healthcare funding in this complex area.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Indivior PLC
Indivior is a pharmaceutical company focused on a single, yet complex, niche: addiction treatment (primarily opioid) and mental health. Their key product is Sublocade. This chart is a summary indicator of their niche. It likely reflects the growth rate of their injectables (which are displacing older oral medications) and their ability to manage legal risks.
AKIMA Market Segment Index - Narco farm
Indivior (INDV) is a pharmaceutical company that dominates (and faces legal risks) the opioid addiction treatment market (Suboxone/Sublocade). This aggregate metric evaluates companies. The graph shows the average value for the segment. This benchmark: how does this high-risk niche (addiction treatment) differentiate Indivior from the average pharmaceutical company?
The AKIM Index for the overall market
Indivior is a pharmaceutical company focused on treating addictions (opioids) and central nervous system disorders. Its key product is Sublocade. It's a protective (healthcare) but niche business. This chart, which reflects the market average, provides a macro backdrop. It helps assess how Indivior fits within the overall macroeconomic picture affecting the sector.
